Redeye is encouraged by Railcare’s new and rather aggressive financial targets of SEK1 billion in sales by 2027 and EBIT margins over 13%. Obviously, the company sees excellent business opportunities in the coming years and has the ambition to further accelerate its expansion. The Q4 report shows continued solid growth and healthy margins. We bump up our near- and mid-term projections.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Railcare - Raising the Bar

© Modular Finance, source Nordic Press Releases